GI & Endoscopy

A late-stage study for Gilead Science's drug to treat fibrosis symptoms associated with nonalcoholic steatohepatitis didn't meet its goal of treating disease symptoms last week.

Fasiha Kanwal, MD, is the gastroenterology and hepatology section chief at Houston-based Baylor College of Medicine.

Here are three GI physicians Becker's ASC Review featured in the last week:

While three private equity firms have invested in gastroenterology to date, several analysts believe more deals are on the way in 2019. 

Medscape's 2019 gastroenterologist compensation report dives into the hours gastroenterologists spend seeing patients and the amount of time they spend on administrative tasks.

Here are the five most-popular articles for GI leaders this week:

CRH Medical posted revenues of $29.1 million for the first quarter of 2019.

Here are six updates from gastroenterology companies and practices from the past week:

Exact Sciences released its first quarter 2019 earnings yesterday, posting a 79 percent gain in quarterly revenues.

Takeda opened its 165,000-square-foot San Diego research center April 30 to support its drug discovery technologies.